RPL17 Antibody - #DF3699
Product: | RPL17 Antibody |
Catalog: | DF3699 |
Description: | Rabbit polyclonal antibody to RPL17 |
Application: | WB IHC IF/ICC |
Reactivity: | Human, Mouse, Rat |
Prediction: | Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Xenopus |
Mol.Wt.: | 24 KD; 21kD(Calculated). |
Uniprot: | P18621 |
RRID: | AB_2836063 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF3699, RRID:AB_2836063.
Fold/Unfold
60S ribosomal protein L17; 60S ribosomal protein L23; FLJ92089; Gene encoding putative NFkB activating protein; L17; MGC117162; PD 1; PD-1; PD1; Ribosomal protein L17; RL17_HUMAN; RPL17; rpL23;
Immunogens
A synthesized peptide derived from human RPL17, corresponding to a region within C-terminal amino acids.
Expressed in pancreas, lung, colon, cystic duct, gall bladder, kidney and liver. Expressed at high levels in the well differentiated pancreatic tumor cell lines HPAF, COLO 357 and Capan-1, the moderately differentiated pancreatic tumor cell lines T3M-4, AsPc-1 and BxPc-3, the poorly differentiated pancreatic tumor cell line MIA PaCa-2, and the pancreatic tumor cell lines of undefined differentiation status such as SW979. Expressed at lower levels in the poorly differentiated pancreatic tumor cell lines HCG-25 and PANC-1.
- P18621 RL17_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MVRYSLDPENPTKSCKSRGSNLRVHFKNTRETAQAIKGMHIRKATKYLKDVTLQKQCVPFRRYNGGVGRCAQAKQWGWTQGRWPKKSAEFLLHMLKNAESNAELKGLDVDSLVIEHIQVNKAPKMRRRTYRAHGRINPYMSSPCHIEMILTEKEQIVPKPEEEVAQKKKISQKKLKKQKLMARE
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P18621 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S5 | Phosphorylation | Uniprot | |
K13 | Ubiquitination | Uniprot | |
S14 | Phosphorylation | Uniprot | |
C15 | S-Nitrosylation | Uniprot | |
K27 | Ubiquitination | Uniprot | |
K37 | Acetylation | Uniprot | |
K37 | Methylation | Uniprot | |
K37 | Sumoylation | Uniprot | |
K37 | Ubiquitination | Uniprot | |
K49 | Acetylation | Uniprot | |
K49 | Ubiquitination | Uniprot | |
K55 | Acetylation | Uniprot | |
K55 | Ubiquitination | Uniprot | |
R69 | Methylation | Uniprot | |
K74 | Acetylation | Uniprot | |
K74 | Ubiquitination | Uniprot | |
K85 | Acetylation | Uniprot | |
K86 | Sumoylation | Uniprot | |
K86 | Ubiquitination | Uniprot | |
S87 | Phosphorylation | Uniprot | |
K96 | Ubiquitination | Uniprot | |
K105 | Ubiquitination | Uniprot | |
K121 | Ubiquitination | Uniprot | |
T129 | Phosphorylation | Uniprot | |
S141 | Phosphorylation | Uniprot | |
S142 | Phosphorylation | Uniprot | |
K159 | Sumoylation | Uniprot | |
K159 | Ubiquitination | Uniprot | |
K167 | Ubiquitination | Uniprot | |
S171 | Phosphorylation | Uniprot |
Research Backgrounds
Component of the large ribosomal subunit.
Expressed in pancreas, lung, colon, cystic duct, gall bladder, kidney and liver. Expressed at high levels in the well differentiated pancreatic tumor cell lines HPAF, COLO 357 and Capan-1, the moderately differentiated pancreatic tumor cell lines T3M-4, AsPc-1 and BxPc-3, the poorly differentiated pancreatic tumor cell line MIA PaCa-2, and the pancreatic tumor cell lines of undefined differentiation status such as SW979. Expressed at lower levels in the poorly differentiated pancreatic tumor cell lines HCG-25 and PANC-1.
Component of the large ribosomal subunit.
Belongs to the universal ribosomal protein uL22 family.
Research Fields
· Genetic Information Processing > Translation > Ribosome.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.